- Home
- RGTI vs CMPX Comparison
RGTI vs CMPX Comparison
Compare RGTI & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGTI
- CMPX
- Stock Information
- Founded
- RGTI 2013
- CMPX 2014
- Country
- RGTI United States
- CMPX United States
- Employees
- RGTI N/A
- CMPX N/A
- Industry
- RGTI Retail: Computer Software & Peripheral Equipment
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- RGTI Technology
- CMPX Health Care
- Exchange
- RGTI Nasdaq
- CMPX Nasdaq
- Market Cap
- RGTI 285.0M
- CMPX 236.7M
- IPO Year
- RGTI N/A
- CMPX N/A
- Fundamental
- Price
- RGTI $1.41
- CMPX $1.38
- Analyst Decision
- RGTI Strong Buy
- CMPX Strong Buy
- Analyst Count
- RGTI 4
- CMPX 3
- Target Price
- RGTI $2.88
- CMPX $7.67
- AVG Volume (30 Days)
- RGTI 12.2M
- CMPX 513.3K
- Earning Date
- RGTI 11-12-2024
- CMPX 11-12-2024
- Dividend Yield
- RGTI N/A
- CMPX N/A
- EPS Growth
- RGTI N/A
- CMPX N/A
- EPS
- RGTI N/A
- CMPX N/A
- Revenue
- RGTI $11,892,000.00
- CMPX $850,000.00
- Revenue This Year
- RGTI $11.96
- CMPX N/A
- Revenue Next Year
- RGTI $87.57
- CMPX $747.71
- P/E Ratio
- RGTI N/A
- CMPX N/A
- Revenue Growth
- RGTI N/A
- CMPX N/A
- 52 Week Low
- RGTI $0.66
- CMPX $0.77
- 52 Week High
- RGTI $2.36
- CMPX $2.34
- Technical
- Relative Strength Index (RSI)
- RGTI 56.21
- CMPX 31.85
- Support Level
- RGTI $1.25
- CMPX $1.74
- Resistance Level
- RGTI $1.89
- CMPX $2.00
- Average True Range (ATR)
- RGTI 0.22
- CMPX 0.14
- MACD
- RGTI 0.01
- CMPX -0.04
- Stochastic Oscillator
- RGTI 42.17
- CMPX 6.06
About RGTI Rigetti Computing Inc.
Rigetti Computing Inc is engaged in the business of full-stack quantum computing. Its proprietary quantum-classical infrastructure provides ultra-low latency integration with public and private clouds for high-performance practical quantum computing. The company has developed the industry's first multi-chip quantum processor for scalable quantum computing systems. Geographically, it derives a majority of its revenue from the United States.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.